Dantrolene, a ryanodine receptor stabilizer, is a candidate immunomodulator for treating rheumatic disease

被引：1
|
作者：
Nawata, T. [1 ,4 ]
Honda, T. [2 ]
Sakai, H. [2 ]
Tsuji, S. [2 ]
Otsuka, M. [2 ]
Uchinoumi, H. [1 ]
Kobayashi, S. [1 ]
Yamamoto, T. [3 ]
Asagiri, M. [2 ]
Yano, M. [1 ]
机构：
[1] Yamaguchi Univ, Dept Med & Clin Sci, Grad Sch Med, Ube, Japan
[2] Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, Ube, Japan
[3] Yamaguchi Univ, Fac Hlth Sci, Grad Sch Med, Ube, Japan
[4] Yamaguchi Univ, Dept Med & Clin Sci, Grad Sch Med, 1-1-1 Minamikogushi, Ube 7558505, Japan
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2024年 / 53卷 / 03期
关键词：
D O I：
10.1080/03009742.2023.2297519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [41] Problems associated with treating ocular disease in underlying inflammatory rheumatic disease
    Zierhut, M.
    Koetter, I.
    Lorenz, H. -M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (05): : 393 - 396
  • [42] Cardiac ryanodine receptor function and regulation in heart disease
    Lehnart, SE
    Wehrens, XHT
    Kushnir, A
    Marks, AR
    CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION, 2004, 1015 : 144 - 159
  • [43] Dantrolene blockade of ryanodine receptor impairs ethanol-induced behavioral stimulation, ethanol intake and loss of righting reflex
    Tarragon, Ernesto
    Balino, Pablo
    Aragon, Carlos M. G.
    BEHAVIOURAL BRAIN RESEARCH, 2012, 233 (02) : 554 - 562
  • [44] Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel - Clinical implications
    Nelson, TE
    Lin, M
    ZapataSudo, G
    Sudo, RT
    ANESTHESIOLOGY, 1996, 84 (06) : 1368 - 1379
  • [45] The 160 kDa dantrolene binding protein is a nucleotide-dependent, n-calpain derived fragment of the ryanodine receptor
    Paul-Pletzer, K
    Palnitkar, SS
    Jimenez, LS
    Parness, J
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 427A - 427A
  • [46] Acute Dantrolene Treatment Reverses Arrhythmogenic Substrate and Reduces Triggers Induced by Ryanodine Receptor 2 Hyperactivity in Human Hearts
    George, Sharon Ann
    Efimov, Igor R.
    CIRCULATION, 2022, 146
  • [47] Fixation of the Disturbing Ryanodine Receptor by Dantrolene Restores Cardiac Dysfunction and Suppreses Ventricular Arrhythmia in Mice Myocardial Infarction Model
    Ishiguchi, Hironori
    Kobayashi, Shigeki
    Kouno, Michiaki
    Nanno, Takuma
    Nishimura, Shigehiko
    Oda, Tetsuro
    Okuda, Shinichi
    Ueyama, Takeshi
    Yamamoto, Takeshi
    Yano, Masafumi
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S212 - S213
  • [48] Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene
    Acsai, Karoly
    Nagy, Norbert
    Marton, Zoltan
    Oravecz, Kinga
    Varro, Andras
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (08) : 1062 - 1072
  • [49] Dantrolene inhibits lysophosphatidylcholine-induced valve interstitial cell calcific nodule formation via blockade of the ryanodine receptor
    Sylvester, Christopher B.
    Amirkhosravi, Farshad
    Bortoletto, Angelina S.
    West III, William J.
    Connell, Jennifer P.
    Grande-Allen, K. Jane
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [50] Stabilizing cardiac ryanodine receptor with dantrolene treatment prevents left ventricular remodeling in pressure-overloaded heart failure mice
    Yano, Yasutake
    Kobayashi, Shigeki
    Uchida, Tomoyuki
    Chang, Yaowei
    Nawata, Junya
    Fujii, Shohei
    Nakamura, Yoshihide
    Suetomi, Takeshi
    Uchinoumi, Hitoshi
    Oda, Tetsuro
    Yamamoto, Takeshi
    Yano, Masafumi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 642 : 175 - 184
12345